Loading
Latest filing published 12 Feb 2024 for ImmunoGen, Inc.. Read the official filing
No signal scores available.
One trade, one date: on 12 February 2024, Daniel Char disclosed a transaction in ImmunoGen, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration